Načítá se...
Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer
Cancer cells with heterogeneous mutation landscapes and extensive functional redundancy easily develop resistance to monotherapies by emerging activation of compensating or bypassing pathways. To achieve more effective and sustained clinical responses, synergistic interactions of multiple druggable...
Uloženo v:
| Vydáno v: | NPJ Syst Biol Appl |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6614366/ https://ncbi.nlm.nih.gov/pubmed/31312514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41540-019-0098-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|